Più Medical: Company presentation avaiable for the IT ICAP Midcap Conference – Integration to the press issued on May 5, 2026
07/05/2026
07/05/2026
Più Medical: Company presentation avaiable for the IT ICAP Midcap Conference – Integration to the press issued on May 5, 2026
Più Medical: first acquisition post IPO
05/05/2026
Più Medical attends the TP ICAP Midcap Conference
05/05/2026
Più Medical attends the “Frankfurt Investor Conference”
15/04/2026
Più Medical: The board of directors approves the 2026 corporate events calendar
27/1/2026
Execution of the capital increase or a total of
C.€5 million
29/12/2025
Internal Dealing “G.S.M.”
15/12/2025
Internal Dealing “La Farmaceutica”
15/12/2025
Banca Investis replaces Value Track as Euronext Growth Advisor
12/12/2025
Final notice on the Stabilisation Activity and the exercise of the Greenshoe option.
11/12/2025
Fulfillment of the commitments made by the Founders with the anchor investor First SICAF upon admission to trading:
11/12/2025
Commitment by the IPO Club 2 Fund (Azimut/Electa) to enter into Più Medical through IPOC S.r.l., a P.I.P.E. vehicle also participated in by the founding shareholders.
10/12/2025
Interim notice during the Stabilisation Period (4 December 2025).
04/12/2025
Interim notice during the Stabilisation Period (26 November 2025).
26/11/2025
Più Medical now listed on Euronext
20/11/2025
Admission to Listing of Più Medical – 18 November 2025
18/11/2025
Successful completion of the placement of Più Medical ordinary shares – 17 November 2025
17/11/2025